Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP4F2 | P78329 | 2/20 | 0.50 |
| ▸ | CYP4A11 | Q02928 | 2/20 | 0.50 |
| ▸ | APP | P05067 | 2/20 | 0.44 |
| ▸ | CYP4Z1 | Q86W10 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.40 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.40 |
| ▸ | GLA | P06280 | 1/20 | 0.40 |
| ▸ | GAA | P10253 | 1/20 | 0.40 |
| ▸ | HPGD | P15428 | 1/20 | 0.40 |
| ▸ | CASP1 | P29466 | 1/20 | 0.40 |
| ▸ | CASP7 | P55210 | 1/20 | 0.40 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 1/20 | 0.39 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.39 |
| ▸ | PDE3B | Q13370 | 1/20 | 0.38 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.38 |
| ▸ | P2RY12 | Q9H244 | 1/20 | 0.38 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.37 |
| ▸ | TRPV1 | Q8NER1 | 2/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3799639 | 0.90 | CYP4F2 (0.45) | CYP4F2CYP4A11CYP4Z1ALDH1A1HPGD | |
| SCHEMBL2302006 | 0.86 | CYP4F2 (0.54) | CYP4F2CYP4A11APPCYP4Z1KDM4E | |
| SCHEMBL491004 | 0.85 | CYP4F2 (0.57) | CYP4F2CYP4A11APPCYP4Z1CYP1A2 | |
| SCHEMBL2347025 | 0.82 | CYP4F2 (0.58) | CYP4F2CYP4A11APPCYP4Z1PDE3B | |
| SCHEMBL3800196 | 0.80 | CYP4F2 (0.46) | CYP4F2CYP4A11CYP4Z1KDM4EALDH1A1 | |
| SCHEMBL17185943 | 0.80 | CYP4F2 (0.55) | CYP4F2CYP4A11CYP4Z1KDM4EALDH1A1 | |
| SCHEMBL3797922 | 0.79 | CYP4F2 (0.44) | CYP4F2CYP4A11CYP4Z1KDM4EALDH1A1 | |
| SCHEMBL3797924 | 0.79 | CYP4F2 (0.44) | CYP4F2CYP4A11CYP4Z1KDM4EALDH1A1 | |
| SCHEMBL7857817 | 0.79 | CYP4F2 (0.57) | CYP4F2CYP4A11CYP4Z1KDM4EHPGD | |
| SCHEMBL17197084 | 0.79 | CYP4F2 (0.50) | CYP4F2CYP4A11CYP4Z1KDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7902394-B2 | Calcilytic compounds | GLAXOSMITHKLINE LLC (US) | 2011-03-08 | — | — | US | disclosed |
| US-20100029782-A1 | Calcilytic Compounds | SMITHKLINE BEECHAM CORPORATION (US) | 2010-02-04 | — | — | US | disclosed |
| EP-2120898-A1 | CALCILYTIC COMPOUNDS | SmithKline Beecham Corporation (US) | 2009-11-25 | — | — | EP | disclosed |
| WO-2008077009-A1 | CALCILYTIC COMPOUNDS | SMITHKLINE BEECHAM CORPORATION (US) | 2008-06-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100029782-A1 | Calcilytic Compounds | CALCR, CALCA, CALCB | CYP4F2 394/4885CYP4A11 282/4885APP 948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.